Department of Mental Health and Social Sciences, Schizophrenia Research Foundation, Chennai, Tamil Nadu, India.
Indian J Psychiatry. 2015 Jan-Mar;57(1):85-7. doi: 10.4103/0019-5545.148532.
Sexual dysfunction (SD) is not commonly reported by persons with schizophrenia unless an enquiry is made by a doctor or staff during routine clinical visits.
A cross-sectional study was carried out to determine reporting of drug-induced sexual side-effects and the attitude of the treating team in clarifying or detecting this issue.
A vast majority of professionals (73.2%) did not enquire about SDs in routine clinical setting and admitted that they lack expertise based on the Attitude Survey Questionnaire. More than one-third of the patients (35.3%) attributed sexual side-effects to medications. Many patients (91.7%) reported good to fair tolerance to sexual side-effects according to the Psychotropic Related Sexual Dysfunction Questionnaire.
The treating team plays a crucial role. Sexual side-effects are often under-reported and need to be addressed by the treating physician.
精神分裂症患者并不常报告性功能障碍（SD），除非医生或医务人员在常规临床就诊时询问。
进行了一项横断面研究，以确定药物引起的性副作用的报告情况以及治疗团队在澄清或发现该问题方面的态度。
绝大多数专业人员（73.2%）在常规临床环境中没有询问 SD 问题，并承认他们根据态度调查问卷调查缺乏专业知识。超过三分之一的患者（35.3%）将性副作用归因于药物。根据精神药物相关性功能障碍问卷，许多患者（91.7%）报告对性副作用有良好到尚可的耐受性。
治疗团队起着至关重要的作用。性副作用经常被漏报，需要由主治医生来解决。
